Question

Difficulty: MediumInfectious Diseases

A 54-year-old woman is evaluated in the oncology ward for a new-onset fever. She is currently on day 10 of induction chemotherapy for acute myeloid leukemia. Her temperature is 38.8°C (101.8°F), blood pressure is 105/65 mmHg, and heart rate is 112/min. Laboratory analysis shows a white blood cell count of 400/mm³ with an absolute neutrophil count (ANC) of 150/mm³. She has a central venous port in her right internal jugular vein.

Arrange the following interventions in the most appropriate chronological sequence for managing this patient's condition.

  1. 1Obtain blood cultures from the central venous port and a peripheral vein.
  2. 2Administer empiric intravenous antipseudomonal therapy (e.g., cefepime).
  3. 3Tailor the antibacterial regimen based on finalized culture and susceptibility results.
  4. 4Initiate empiric intravenous antifungal therapy if the patient remains febrile after 4 to 7 days.

Answer

The correct sequence for managing neutropenic fever is to first obtain appropriate blood cultures, immediately follow with empiric antipseudomonal antibiotics, later tailor the regimen based on culture results, and finally add empiric antifungal therapy if the fever persists beyond 4 to 7 days.
The standard protocol for neutropenic fever requires an immediate, sequential approach. Blood cultures must be drawn first to identify the organism, followed urgently by empiric antipseudomonal antibiotics to prevent septic shock. Once culture results return (usually 48-72 hours later), the antibiotics are tailored. Finally, if the patient remains febrile and neutropenic after 4 to 7 days, empiric antifungal therapy is added.

Step-by-Step Solution

1
Obtain blood cultures from the central venous port and a peripheral vein.
Samples are sent for microbiologic analysis.
Blood cultures must be drawn before starting antibiotics to prevent sterilization of the sample and allow for the identification of the causative pathogen.
2
Administer empiric intravenous antipseudomonal therapy (e.g., cefepime).
The patient receives broad-spectrum antibacterial coverage.
Neutropenic patients lack the immune response to control infections; delaying empiric antibiotics significantly increases the risk of mortality.
3
Tailor the antibacterial regimen based on finalized culture and susceptibility results.
Antibiotics are de-escalated or adjusted.
Once the pathogen and its susceptibilities are known, targeted therapy reduces the risk of resistance and medication toxicity, adhering to principles of antimicrobial stewardship.
4
Initiate empiric intravenous antifungal therapy if the patient remains febrile after 4 to 7 days.
The patient receives coverage for invasive fungal pathogens.
Persistent fever in a profoundly neutropenic patient despite broad-spectrum antibiotics suggests a high likelihood of an underlying fungal infection, most commonly Candida or Aspergillus species.

Key Concept

The chronological management algorithm for neutropenic fever prioritizes immediate cultures and empiric antipseudomonal antibiotics, followed by culture-directed tailoring, and reserves empiric antifungals for those who remain febrile after 4 to 7 days.
Estimated Time:1m 0s
Rate this question